Evidence Hub

Gut microbiota in dysmenorrhea: causal evidence from Mendelian randomization and microbial-targeted intervention validation

Yajie Qin, Rui Ma, Lili Zhang, Xiaotian Yang, Huifang Zhou, Yanping Wang

Frontiers in Microbiology, 2026

1 citation

Abstract

Background Dysmenorrhea is a prevalent gynecological disorder with multifactorial pathophysiology, including prostaglandin overproduction, inflammation, and pain sensitization. Emerging evidence suggests that gut microbiota may contribute to pain modulation, although causal relationships remain unclear. Methods Bidirectional two-sample Mendelian randomization (MR) was performed to investigate causal associations between dysmenorrhea and gut microbiota. Complementary in vivo validation was conducted in a primary dysmenorrhea (PDM) rat model treated with ibuprofen or the traditional Chinese medicine Wenjing Zhitong Decoction (WJZTD). The gut microbiota composition was analyzed using 16S rRNA sequencing, and correlations with pain-related parameters were assessed. Results Forward MR analyses revealed that genetic liability to dysmenorrhea influenced the abundance of specific gut taxa, notably reducing Lachnospiraceae genera and increasing Erysipelotrichaceae, which was consistent with observed alterations in PDM rats. Reverse MR provided no robust evidence that gut microbiota causally affect dysmenorrhea. In the PDM model, both ibuprofen and WJZTD produced analgesic effects, but induced distinct microbial signatures: ibuprofen increased the presence of Staphylococcus , while WJZTD enriched the population of Bifidobacterium . Correlation analyses highlighted Blautia as a microbiota feature associated with reduced pain, suggesting that modulation of this genus may represent a…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free